JPMorgan Adjusts Price Target on Zimmer Biomet to $117 From $95
JPMorgan has raised its price target for Zimmer Biomet Holdings, Inc. (ZBH) to $117 from $95. This adjustment was reported on August 6, 2026, at 12:02 pm EDT. The article also notes several other analyst adjustments for Zimmer Biomet on the same day.
Why it matters
Attributed market update with source link for portfolio context.